<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Consumer Medical Reports</title>
	<atom:link href="http://www.consumermedicalreports.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.consumermedicalreports.net</link>
	<description>Medical Reports on Todays Health Ailments.</description>
	<lastBuildDate>Wed, 25 Jul 2012 10:30:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.1</generator>
		<item>
		<title>Regeneron Reports Second Quarter 2012 Financial and Operating Results</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/regeneron-reports-second-quarter-2012-financial-and-operating-results/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/regeneron-reports-second-quarter-2012-financial-and-operating-results/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:30:00 +0000</pubDate>
		<dc:creator>Regeneron Pharmaceuticals, Inc.</dc:creator>
				<category><![CDATA[Earnings]]></category>
		<category><![CDATA[Earnings Forecasts & Projections]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/regeneron-reports-second-quarter-2012-financial-and-operating-results-163669026.html</guid>
		<description><![CDATA[TARRYTOWN, N.Y., July 25, 2012 /PRNewswire/ --&#160;Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the second quarter of 2012 and provided an update on development programs.&#160; 

The Company report...]]></description>
			<content:encoded><![CDATA[<p>TARRYTOWN, N.Y., July 25, 2012 /PRNewswire/ &#8211;&#160;Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the second quarter of 2012 and provided an update on development programs.&#160; </p>
<p>The Company reported total revenues of $304 million in&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/regeneron-reports-second-quarter-2012-financial-and-operating-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lilly Reports Second-Quarter 2012 Results, Raises 2012 EPS Guidance</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/lilly-reports-second-quarter-2012-results-raises-2012-eps-guidance/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/lilly-reports-second-quarter-2012-results-raises-2012-eps-guidance/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:30:00 +0000</pubDate>
		<dc:creator>Eli Lilly and Company</dc:creator>
				<category><![CDATA[Earnings]]></category>
		<category><![CDATA[Earnings Forecasts & Projections]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/lilly-reports-second-quarter-2012-results-raises-2012-eps-guidance-163669036.html</guid>
		<description><![CDATA[INDIANAPOLIS, July 25, 2012 /PRNewswire/ --


Worldwide revenue declined 10 percent to $5.6 billion, driven by Zyprexa patent expirations, partially offset by significant growth in other products. 
Cymbalta revenue increased 22 percent due to continued...]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.prnewswire.com/news-releases/lilly-reports-second-quarter-2012-results-raises-2012-eps-guidance-163669036.html"><img style="padding-right:5px;" src="http://photos.prnewswire.com/prn/20031219/LLYLOGO" align="left"  width="144" alt="http://photos.prnewswire.com/prnc/20031219/LLYLOGO" border="0" /></a>INDIANAPOLIS, July 25, 2012 /PRNewswire/ &#8211;</p>
<p>Worldwide revenue declined 10 percent to $5.6 billion, driven by Zyprexa patent expirations, partially offset by significant growth in other products.<br />
Cymbalta revenue increased 22 percent due to continued strong growth in both the U.S. and&#8230;</p>
<p><br clear="all"/></p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/lilly-reports-second-quarter-2012-results-raises-2012-eps-guidance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://photos.prnewswire.com/prn/20031219/LLYLOGO" length="" type="image/jpeg" />
		</item>
		<item>
		<title>Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/actinium-pharmaceuticals-inc-pays-regulatory-milestone-to-abbott-biotherapeutics-corp/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/actinium-pharmaceuticals-inc-pays-regulatory-milestone-to-abbott-biotherapeutics-corp/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:30:00 +0000</pubDate>
		<dc:creator>Actinium Pharmaceuticals Inc.</dc:creator>
				<category><![CDATA[Clinical Trials & Medical Discoveries]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-pays-regulatory-milestone-to-abbott-biotherapeutics-corp-163668956.html</guid>
		<description><![CDATA[NEWARK, N.J., July 25, 2012 /PRNewswire/ --&#160;Actinium Pharmaceuticals Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that the Company made a regulatory milestone payment to Abbott Bio...]]></description>
			<content:encoded><![CDATA[<p>NEWARK, N.J., July 25, 2012 /PRNewswire/ &#8211;&#160;Actinium Pharmaceuticals Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that the Company made a regulatory milestone payment to Abbott Biotherapeutics Corp. following the&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/actinium-pharmaceuticals-inc-pays-regulatory-milestone-to-abbott-biotherapeutics-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Whelen Racing And Danville D&#8217;elegance (DDE) Foundation Partner To Offer &quot;Join The GRAND-AM VIP Experience&quot; Charity Auction Package On eBay</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/whelen-racing-and-danville-delegance-dde-foundation-partner-to-offer-join-the-grand-am-vip-experience-charity-auction-package-on-ebay/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/whelen-racing-and-danville-delegance-dde-foundation-partner-to-offer-join-the-grand-am-vip-experience-charity-auction-package-on-ebay/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:21:00 +0000</pubDate>
		<dc:creator>Danville d’Elegance Foundation</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>
		<category><![CDATA[Not For Profit]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/whelen-racing-and-danville-delegance-dde-foundation-partner-to-offer-join-the-grand-am-vip-experience-charity-auction-package-on-ebay-163668486.html</guid>
		<description><![CDATA[DANVILLE, Calif., July 25, 2012 /PRNewswire/ --&#160;Ever wonder how it feels to own a GRAND-AM racing team -- or better yet, to feel the camaraderie and excitement as a member of a Rolex GT Sports Car team? Now you can get a "behind-the-scenes" look a...]]></description>
			<content:encoded><![CDATA[<p>DANVILLE, Calif., July 25, 2012 /PRNewswire/ &#8211;&#160;Ever wonder how it feels to own a GRAND-AM racing team &#8212; or better yet, to feel the camaraderie and excitement as a member of a Rolex GT Sports Car team? Now you can get a &#8220;behind-the-scenes&#8221; look at GRAND-AM racing at the&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/whelen-racing-and-danville-delegance-dde-foundation-partner-to-offer-join-the-grand-am-vip-experience-charity-auction-package-on-ebay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Giving Hope Program Offers Fertility Treatment Discounts to Couples in Need</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/giving-hope-program-offers-fertility-treatment-discounts-to-couples-in-need/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/giving-hope-program-offers-fertility-treatment-discounts-to-couples-in-need/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:00:00 +0000</pubDate>
		<dc:creator>Reproductive Science Center</dc:creator>
				<category><![CDATA[Corporate Social Responsibility]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/giving-hope-program-offers-fertility-treatment-discounts-to-couples-in-need-163667476.html</guid>
		<description><![CDATA[SAN FRANCISCO EAST BAY, Calif., July 25, 2012 /PRNewswire/ -- Reproductive Science Center is proud to announce the Giving Hope Program for patients.

The Giving Hope Program offers a 15 percent discount to patients with little or no insurance coverage ...]]></description>
			<content:encoded><![CDATA[<p>SAN FRANCISCO EAST BAY, Calif., July 25, 2012 /PRNewswire/ &#8212; Reproductive Science Center is proud to announce the Giving Hope Program for patients.</p>
<p>The Giving Hope Program offers a 15 percent discount to patients with little or no insurance coverage and limited personal resources for&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/giving-hope-program-offers-fertility-treatment-discounts-to-couples-in-need/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RxAlly Adds Nationally Recognized Health Care Policy Professional Wayne Oliver To The Company&#8217;s Leadership Team</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/rxally-adds-nationally-recognized-health-care-policy-professional-wayne-oliver-to-the-companys-leadership-team/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/rxally-adds-nationally-recognized-health-care-policy-professional-wayne-oliver-to-the-companys-leadership-team/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 10:00:00 +0000</pubDate>
		<dc:creator>RxAlly</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>
		<category><![CDATA[Personnel Announcements]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/rxally-adds-nationally-recognized-health-care-policy-professional-wayne-oliver-to-the-companys-leadership-team-163667526.html</guid>
		<description><![CDATA[LEESBURG, Va., July 25, 2012 /PRNewswire/ --&#160;RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today the addition of Wayne Oliver to the company's leadership team.&#160; Mr. Oliver will serve as Vice Preside...]]></description>
			<content:encoded><![CDATA[<p>LEESBURG, Va., July 25, 2012 /PRNewswire/ &#8211;&#160;RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today the addition of Wayne Oliver to the company&#8217;s leadership team.&#160; Mr. Oliver will serve as Vice President for Pharmacy Advocacy and&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/rxally-adds-nationally-recognized-health-care-policy-professional-wayne-oliver-to-the-companys-leadership-team/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Undiagnosed Heart Problems Threatening The Health And Quality Of Life Of The Very Elderly</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/undiagnosed-heart-problems-threatening-the-health-and-quality-of-life-of-the-very-elderly/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/undiagnosed-heart-problems-threatening-the-health-and-quality-of-life-of-the-very-elderly/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 09:00:00 +0000</pubDate>
		<dc:creator>Health News from Medical News Today</dc:creator>
				<category><![CDATA[Cardiovascular / Cardiology]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.medicalnewstoday.com/releases/248224.php</guid>
		<description><![CDATA[The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say. Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle Univers...]]></description>
			<content:encoded><![CDATA[<p>The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say. Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments&#8230;<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ZphJ9ckk14s" height="1" width="1"/></p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/undiagnosed-heart-problems-threatening-the-health-and-quality-of-life-of-the-very-elderly/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Higher Incidence Of Diabetes In Native-Americans Linked To Fat-Hoarding Genes Likely Developed Due To The Nature Of Ancient Feasts</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/higher-incidence-of-diabetes-in-native-americans-linked-to-fat-hoarding-genes-likely-developed-due-to-the-nature-of-ancient-feasts/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/higher-incidence-of-diabetes-in-native-americans-linked-to-fat-hoarding-genes-likely-developed-due-to-the-nature-of-ancient-feasts/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 09:00:00 +0000</pubDate>
		<dc:creator>Health News from Medical News Today</dc:creator>
				<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.medicalnewstoday.com/releases/248222.php</guid>
		<description><![CDATA[Why do Native Americans experience high rates of diabetes? A common theory is that they possess fat-hoarding "thrifty genes" left over from their ancestors - genes that were required for survival during ancient cycles of feast and famine, but that now ...]]></description>
			<content:encoded><![CDATA[<p>Why do Native Americans experience high rates of diabetes? A common theory is that they possess fat-hoarding &#8220;thrifty genes&#8221; left over from their ancestors &#8211; genes that were required for survival during ancient cycles of feast and famine, but that now contribute to the disease in a modern world of more fatty and sugary diets. A newly published analysis of fossilized feces from the American Southwest, however, suggests this &#8220;thrifty gene&#8221; may not have developed because of how often ancient Natives ate. Instead, researchers said, the connection may have come from precisely what they ate&#8230;<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/-YQss-A-6ac" height="1" width="1"/></p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/higher-incidence-of-diabetes-in-native-americans-linked-to-fat-hoarding-genes-likely-developed-due-to-the-nature-of-ancient-feasts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>sigma tau group gestionará directamente la distribución de Oncaspar® desde el 1 de agosto</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/sigma-tau-group-gestionara-directamente-la-distribucion-de-oncaspar-desde-el-1-de-agosto/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/sigma-tau-group-gestionara-directamente-la-distribucion-de-oncaspar-desde-el-1-de-agosto/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 08:02:00 +0000</pubDate>
		<dc:creator>Sigma-Tau Group</dc:creator>
				<category><![CDATA[Contracts]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>
		<category><![CDATA[New Products & Services]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/sigma-tau-group-gestionara-directamente-la-distribucion-de-oncaspar-desde-el-1-de-agosto-163662476.html</guid>
		<description><![CDATA[ROMA, July 25, 2012 /PRNewswire/ --

- Desde el 1 de agosto de 2012, sigma tau group gestionar&#225; de forma directa la distribuci&#243;n de Oncaspar&#174;, un f&#225;rmaco para el tratamiento de la leucemia, en Europa, Asia y Australia

Oncaspar, ind...]]></description>
			<content:encoded><![CDATA[<p>ROMA, July 25, 2012 /PRNewswire/ &#8211;</p>
<p>- Desde el 1 de agosto de 2012, sigma tau group gestionar&#225; de forma directa la distribuci&#243;n de Oncaspar&#174;, un f&#225;rmaco para el tratamiento de la leucemia, en Europa, Asia y Australia</p>
<p>Oncaspar, indicado para el tratamiento de la&#8230;</p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/sigma-tau-group-gestionara-directamente-la-distribucion-de-oncaspar-desde-el-1-de-agosto/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ZERONA® Laser Proves a Success in Munich</title>
		<link>http://www.consumermedicalreports.net/latest-health-news/zerona-laser-proves-a-success-in-munich/</link>
		<comments>http://www.consumermedicalreports.net/latest-health-news/zerona-laser-proves-a-success-in-munich/#comments</comments>
		<pubDate>Wed, 25 Jul 2012 08:00:00 +0000</pubDate>
		<dc:creator>Primcogent Solutions</dc:creator>
				<category><![CDATA[Clinical Trials & Medical Discoveries]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Latest Health News]]></category>

		<guid isPermaLink="false">http://www.prnewswire.com/news-releases/zerona-laser-proves-a-success-in-munich-163662166.html</guid>
		<description><![CDATA[ABINGDON, England, July 25, 2012 /PRNewswire/ --

Initial reports from Munich highlight positive results with the ZERONA laser

Trials of the non-invasive ZERONA&#174; laser, manufactured by ERCHONIA in Munich, Germany, have demonstrated the significan...]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.prnewswire.com/news-releases/zerona-laser-proves-a-success-in-munich-163662166.html"><img style="padding-right:5px;" src="http://photos.prnewswire.com/prn/20120719/546037-a/" align="left"  width="144" alt="http://photos.prnewswire.com/prnc/20120719/546037-a/" border="0" /></a>ABINGDON, England, July 25, 2012 /PRNewswire/ &#8211;</p>
<p>Initial reports from Munich highlight positive results with the ZERONA laser</p>
<p>Trials of the non-invasive ZERONA&#174; laser, manufactured by ERCHONIA in Munich, Germany, have demonstrated the significant body sculpting benefits of Low&#8230;</p>
<p><br clear="all"/></p>
to read more about the author visit -  <a rel="author" href="https://plus.google.com/u/4/106878786754091274665" ">Rafael Fisher</a>]]></content:encoded>
			<wfw:commentRss>http://www.consumermedicalreports.net/latest-health-news/zerona-laser-proves-a-success-in-munich/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://photos.prnewswire.com/prn/20120719/546037-a/" length="" type="image/jpeg" />
		</item>
	</channel>
</rss>
<!-- This Quick Cache file was built for (  www.consumermedicalreports.net/feed/ ) in 7.54612 seconds, on May 26th, 2013 at 7:59 am UTC. -->
<!-- This Quick Cache file will automatically expire ( and be re-built automatically ) on May 26th, 2013 at 8:59 am UTC -->